Evidence map›Paper›PMID 32895618›Full record

ArticleImmune network2020

Adjuvanticity of Processed

Eun-Jung Song, Erica Españo, Jeong-Hyun Nam, Jiyeon Kim, Kyu-Suk Shim, Eunju Shin, Young In Park, Chong-Kil Lee, Jeong-Ki Kim

Open access · diamondAbstract read
In one paragraph

Article in Immune network, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Enhancing effects ofJournal of advanced veterinary and animal research · 2024
    Article
  2. Article
  3. Utilization ofPharmaceuticals (Basel, Switzerland) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Eun-Jung SongDepartment of Pharmacy, Korea University College of Pharmacy, Sejong 30019, Korea.ORCID https://orcid.org/0000-0002-1495-488X
Erica EspañoDepartment of Pharmacy, Korea University College of Pharmacy, Sejong 30019, Korea.ORCID https://orcid.org/0000-0003-1437-9069
Jeong-Hyun NamDepartment of Pharmacy, Korea University College of Pharmacy, Sejong 30019, Korea.
Jiyeon KimDepartment of Pharmacy, Korea University College of Pharmacy, Sejong 30019, Korea.
Kyu-Suk ShimUnivera Co., Ltd., Seoul 04782, Korea.
Eunju ShinUnivera Co., Ltd., Seoul 04782, Korea.
Young In ParkDepartment of Pharmacy, Korea University College of Pharmacy, Sejong 30019, Korea.
Chong-Kil LeeDepartment of Pharmaceutics, College of Pharmacy, Chungbuk National University, Cheongju 28644, Korea.ORCID https://orcid.org/0000-0001-9070-341X
Jeong-Ki KimDepartment of Pharmacy, Korea University College of Pharmacy, Sejong 30019, Korea.ORCID https://orcid.org/0000-0003-1520-1377
Korea University · KRChonnam National University · KRChungbuk National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The effectiveness of current influenza vaccines is considered suboptimal, and 1 way to improve the vaccines is using adjuvants. However, the current pool of adjuvants used in influenza vaccination is limited due to safety concerns.

Indexed as

Aloe veraImmunological adjuvantInfluenza A virusInfluenza B virusVaccines

Identifiers

PMID32895618
PMCPMC7458799
OpenAlexW3046594439

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.